基于复杂生物体系的噬菌体随机肽库筛选

近年来,噬菌体肽库生物淘筛方法又取得了新的进展,出现了以活细胞、病毒及组织器官等复杂生物体系,代替纯化的抗原、抗体或受体分子等作为筛选靶标的方法,并取得了较好的应用效果. 其中,以肿瘤组织筛选噬菌体肽库获得的短肽能选择性富集于肿瘤组织,在肿瘤靶向性治疗中具有潜在的应用前景.     

病毒颗粒:药物靶向传递领域中的新型载体

由于具有高效靶向药物传递的潜力,病毒颗粒已成为药物和生命科学领域的研究焦点.病毒颗粒具有病毒性载体和非病毒性载体的优点,同时克服了两者的局限性.病毒颗粒药物传递系统具有无毒、生物相容性、生物可降解性和非自动免疫等特点.研究表明,病毒颗粒能够在细胞间转运多种具有生物活性的分子,例如核酸或者基因、多肽、蛋白质以及其它抗癌药物等,因此在疾病治疗方面可能具有重要作用.如何制备携带有生物活性材料和治疗试剂的病毒颗粒和确定病毒颗粒药物的最佳剂型是目前该领域中挑战性的课题.本文综述了病毒颗粒技术多方面的特征及应用前景.     

检测病毒气溶胶存活的方法学研究

以钝齿棒状杆菌噬菌体B271血清型为病毒等小颗粒生物粒子的模拟剂,建立了一种适合这类小颗粒生物粒子气溶胶存活研究的方法。本文从该噬菌体耐气溶胶化特性、气溶胶粒谱、用气溶胶示踪剂求算物理衰亡的方法和气溶胶采样回收技术等方面探讨了病毒气溶胶存活研究中的几个关键技术问题,为病毒气溶胶存活研究提供了参考。     

RNA病毒作为疫苗载体的研究与应用

在目前的疫苗研究中,对新疫苗免疫效果的要求越来越高。减毒或无毒的病毒疫苗载体能够激发高效持久的系统和黏膜免疫,并且具有较高的安全性,为研究新疫苗提供了一条途径。RNA病毒作为疫苗载体,在可操作性和免疫效果方面有着显著的优势,近年来已成为疫苗研究领域的热点。综述了几种RNA病毒载体目前的研究状况及其在疫苗载体方面的应用。     

污水生物处理中的噬菌体及其功能研究进展

污水生物处理是一种利用微生物分解污水中的污染物、实现污水净化的方法。噬菌体是侵染细菌的病毒,在污水生物处理系统中广泛存在,它们能够特异性地控制微生物菌群,影响污水处理效果和调控污泥性状。因此,研究污水生物处理中噬菌体的分布及其功能具有重要意义。本文介绍了不同污水生物处理中噬菌体的分布,简要分析了噬菌体分离、培养与鉴定方法及其优缺点,详细总结了噬菌体在污水生物处理中的功能,包括:(1)调节微生物群落结构,影响污水处理效果;(2)作为环境监测的指示生物;(3)控制病原菌、污泥膨胀、污泥发泡和膜污染;(4)减少污泥产量,重点分析了影响噬菌体功能的因素,探讨了污水生物处理中噬菌体功能应用存在的问题及其解决方法,最后对噬菌体未来应用的发展方向进行了展望,以期为污水生物处理技术和工艺的开发与应用提供参考,促进污水处理健康发展。     

植物病毒学的研究进展

1国内外植物病毒的研究进展 植物病毒是病毒学科的一个重要组成部分,从病毒学的发展历史来看,一些开创性的工作和基础理论研究成果最先是在植物病毒领域里取得的.这类病原物给很多重要经济作物造成巨大危害,全世界每年农作物的损失达200亿美元.20世纪初对植物病毒学的研究主要集中在植物病理学领域,随着社会的发展和科学技术的进步,植物病毒与生物化学、生物物理学、免疫学、医药学等相关学科相互影响、相互渗透,尤其是在生物化学、分子生物学、植物基因工程技术、信息科学等领域的飞速发展,以及新技术新方法的不断应用,病毒学发展焕然一新.我们的研究手段已经从细菌过滤器、电子显微镜、X射线衍射法、扫描投射电镜过渡到现代分子生物学技术的应用如分子克隆、重组、体外表达等;这些方法的应用使得研究学者们对植物病毒的研究从形态、结构、组成及病毒核酸和蛋白质大分子的超微结构的观察,深入到近年来的对植物病毒基因组核苷酸序列的分析和氨基酸组成及结构功能上,进一步揭示了一些植物病毒的本质特征,使人们对植物病毒有了更深刻地认识,无论是在理论上还是在应用上都有了很大发展.     

噬菌体展示技术在疫苗研究中的应用进展

噬菌体是一种以细菌为宿主的具有严格宿主特异性的病毒,近年来由于分子生物学和基因重组技术的长足发展,藉助噬菌体的基本特性创立和发展了噬菌体展示技术,此项技术将外源肽或蛋白与特定噬菌体衣壳蛋白融合并展示于噬菌体表面。利用这项技术制作的疫苗具有安全可靠、稳定性高、免疫效果好等优点,因此,在新型疫苗的研制上具有很大的应用价值。就噬菌体展示技术及其在疫苗研究中的优势、预防性疫苗与治疗性疫苗的研究进展予以综述。     

反转录病毒基因治疗载体及其安全性评价

反转录病毒载体是目前基因治疗中应用最广泛的基因运载工具之一,具有能稳定整合入宿主细胞、持久表达目的基因、感染细胞范围广、基因容量较大等优点,但其生物安全性还存在争议。在简要介绍反转录基因治疗病毒载体的基础上,对反转录病毒载体中外源目的基因的表达调控及反转录病毒载体的安全性评价进行了综述。     

水体病毒浓缩条件的优化

病毒浓缩条件的优化是水环境病毒污染监测及灭活去除效率评价的基础,本文开发了在待浓缩水样中预先加入钠化蒙脱石吸附病毒以增加其沉降性能,并在优化絮凝条件下用聚合氯化铝絮凝沉淀蒙脱石钠的水体病毒浓缩方法。该方法对人为污染的脊髓灰质炎病毒(Poliovirus 1,PV1)、烟草花叶病毒(Tobacco mosaic virus,TMV)、大肠杆菌噬菌体(Phage of Ecoli,E．cp)在闽汀水、生活污水、自来水中分别有高于84．3％的浓缩回收率,说明该浓缩方法具有较广泛的适用性和应用前景,可为水体病毒污染监测及灭活去除评价提供一个简便、回收率高、成本低的浓缩方法。     

土壤原生动物对环境污染的生物指示作用

土壤原生动物具有丰富的种类和巨大的生物量,在土壤生态系统中具有十分重要的地位．作为指示生物,土壤原生动物具有与其他土壤动物相比更独特的优势．研究它们的群落结构、数量及多样性动态变化,可以很好地评价和监测自然环境变化及人类活动带来的环境污染．本文根据国内外相关文献,简要概述了土壤原生动物在生态系统中的作用．对原生动物的生物指示物优势、土壤原生动物对环境因子响应和污染指示作用及对大气CO2浓度变化的响应等进行了论述,并对土壤原生动物在生态毒理诊断中的应用前景进行了展望．     

The viral approach to breast cancer immunotherapy

Despite years of intensive research, breast cancer remains the leading cause of death in women worldwide. New technologies including oncolytic virus therapies, virus, and phage display are among the most powerful and advanced methods that have emerged in recent years with potential applications in cancer prevention and treatment. Oncolytic virus therapy is an interesting strategy for cancer treatment. Presently, a number of viruses from different virus families are under laboratory and clinical investigation as oncolytic therapeutics. Oncolytic viruses (OVs) have been shown to be able to induce and initiate a systemic antitumor immune response. The possibility of application of a multimodal therapy using a combination of the OV therapy with immune checkpoint inhibitors and cancer antigen vaccination holds a great promise in the future of cancer immunotherapy. Display of immunologic peptides on bacterial viruses (bacteriophages) is also increasingly being considered as a new and strong cancer vaccine delivery strategy. In phage display immunotherapy, a peptide or protein antigen is presented by genetic fusions to the phage coat proteins, and the phage construct formulation acts as a protective or preventive vaccine against cancer. In our laboratory, we have recently tested a few peptides (E75, AE37, and GP2) derived from HER2/neu proto-oncogene as vaccine delivery modalities for the treatment of TUBO breast cancer xenograft tumors of BALB/c mice. Here, in this paper, we discuss the latest advancements in the applications of OVs and bacterial viruses display systems as new and advanced modalities in cancer immune therapeutics.     

In vitro DNA packaging of PRD1: a common mechanism for internal-membrane viruses

PRD1 is the type virus of the Tectiviridae family. Its linear double-stranded DNA genome has covalently attached terminal proteins and is surrounded by a membrane, which is further enclosed within an icosahedral protein capsid. Similar to tailed bacteriophages, PRD1 packages its DNA into a preformed procapsid. The PRD1 putative packaging ATPase P9 is a structural protein located at a unique vertex of the capsid. An in vitro system for packaging DNA into preformed empty procapsids was developed. The system uses cell extracts of overexpressed P9 protein and empty procapsids from a P9-deficient mutant virus infection and PRD1 DNA containing a LacZalpha-insert. The in vitro packaged virions produce distinctly blue plaques when plated on a suitable host. This is the first time that a viral genome is packaged in vitro into a membrane vesicle. Comparison of PRD1 P9 with putative packaging ATPase sequences from bacterial, archaeal and eukaryotic viruses revealed a new packaging ATPase-specific motif. Surprisingly the viruses having this packaging ATPase motif, and thus considered to be related, were the same as those recently grouped together using the coat protein fold and virion architecture. Our finding here strongly supports the idea that all these viruses infecting hosts in all domains of life had a common ancestor.     

Building a virus from scratch: assembly of an infectious virus using purified components in a rigorously defined biochemical assay system

The assembly of double-stranded DNA (dsDNA) viruses such as poxvirus, the herpesviruses and many bacteriophages is a complex process that requires the coordinated activities of numerous proteins of both viral and host origin. Here, we report the assembly of an infectious wild-type lambda virus using purified proteins and commercially available DNA, and optimization of the assembly reaction in a rigorously defined biochemical system. Seven proteins, purified procapsids and tails, and mature lambda DNA are necessary and sufficient for efficient virus assembly in vitro. Analysis of the reaction suggests that (i) virus assembly in vitro is optimal under conditions that faithfully mimic the intracellular environment within an Escherichia coli cell, (ii) concatemeric DNA is required for the successful completion of virus assembly, (iii) several of the protein components oligomerize concomitant with their step-wise addition to the nascent virus particle and (iv) tail addition is the rate-limiting step in virus assembly. Importantly, the assembled virus may enter either of the developmental pathways (lytic or lysogenic) expected of a lambda virion. Thus, we demonstrate for the first time that a wild-type, complex DNA virus may be assembled from purified components under defined biochemical conditions. This system provides a powerful tool to characterize, at the molecular level, the step-by-step processes required to assemble an infectious virus particle. Given the remarkable similarities between dsDNA bacteriophage and eukaryotic dsDNA viruses, characterization of the lambda system has broad biological implications in our understanding of virus development at a global level.     

保护性病毒抗原的筛选策略及其在新型疫苗研发中的应用

随着疫苗研发技术的发展,新型疫苗在传染病的预防中得到了广泛应用。由于新型疫苗安全性良好,因此其在烈性病疫苗的应用中有着得天独厚的优势,然而研制新型疫苗的前提是筛选出保护性抗原。随着各种组学研究的发展,针对真核生物的多种生物信息学方法代表着最前沿的技术手段。相对于真核细胞,病毒具有更为简单的结构,对应着相对简单的研究方法,未来的保护性抗原筛选策略,需要结合生物信息学和传统分子生物学方法的优势。本文分别从宿主和病毒入手,论述了病毒保护性抗原的筛选策略,列举了一系列基于真核细胞开发的可能用于保护性抗原筛选的生物信息学方法,并总结了应用保护性抗原进行新型疫苗设计的案例,以便加深对病毒保护性抗原筛选策略的认知,为新型疫苗的研发提供借鉴。     

RNA 沉默的病毒抑制子

RNA 沉默是一种在真核生物体内普遍保守的、通过核酸序列特异性的相互作用来抑制基因表达的调控机制 . RNA 沉默的一种重要生物学效应是防御病毒的侵染,而针对寄主的这种防御机制,许多植物病毒已演化通过编码 RNA 沉默的抑制子来克服这种防御反应 . 目前,已从植物、动物和人类病毒中鉴定了 20 多种 RNA 沉默的抑制子,围绕抑制子的鉴定和作用机理研究已成为病毒学研究的一个热点 . 对 RNA 沉默抑制子的发现、鉴定方法、作用机理及与病毒病症状形成的关系、动物病毒的沉默抑制子等方面的最新进展做了综述,并对沉默抑制子的应用和存在的问题进行了讨论 .     

综述与专论: 树鼩病毒感染模型的研究新进展

病毒感染引起的疾病接近中国主要传染病发病率的一半,也是传染病致死的主要病因。建立与人类亲缘关系较近、方便有效的感染人类病毒的动物模型,对了解病毒的生物学特性、感染致病机理及制定有效防控措施具有重要意义。树鼩作为灵长类动物的近亲,与人类在生理生化、基因组学等方面的相似性远高于大鼠、小鼠等常用啮齿类实验动物,并具有个体小、便于实验操作、饲养成本低、能感染多种人类病毒等特点,作为动物模型在病毒感染性疾病研究中突显优势和潜能。本文从地区分布、进化、生物学特性等方面,阐述了树鼩作为动物模型应用于病毒感染性疾病研究的优势,包括在乙型肝炎病毒、甲型肝炎病毒,及其他病毒感染疾病研究中的进展。     

重组酶聚合酶扩增技术在植物病毒检测中的应用

随着分子生物学技术的发展,多种核酸等温扩增技术逐渐被开发出来。其中,重组酶聚合酶扩增(recombinase polymerase amplification,RPA)作为一种快速、灵敏的检测技术具有很大的优势。目前,RPA已应用于转基因生物、各类病原物及食品安全检测等多个领域,并作为新兴技术在植物病毒检测领域中快速发展。RPA技术只需一对引物,在恒温条件下(37-42℃)只需30 min左右即可完成反应,具有较高的灵敏度与特异性。因此,该技术正迅速成为一种能够用于条件有限的实验室或现场植物病毒检测的手段。本文介绍了RPA技术的检测原理、引物设计和应用方式,综述了其在植物病毒检测中的最新研究进展及存在的问题,为RPA技术在植物病毒检测中的应用提供参考。     

Constituents of SH1, a novel lipid-containing virus infecting the halophilic euryarchaeon Haloarcula hispanica

Recent studies have indicated that a number of bacterial and eukaryotic viruses that share a common architectural principle are related, leading to the proposal of an early common ancestor. A prediction of this model would be the discovery of similar viruses that infect archaeal hosts. Our main interest lies in icosahedral double-stranded DNA (dsDNA) viruses with an internal membrane, and we now extend our studies to include viruses infecting archaeal hosts. While the number of sequenced archaeal viruses is increasing, very little sequence similarity has been detected between bacterial and eukaryotic viruses. In this investigation we rigorously show that SH1, an icosahedral dsDNA virus infecting Haloarcula hispanica, possesses lipid structural components that are selectively acquired from the host pool. We also determined the sequence of the 31-kb SH1 genome and positively identified genes for 11 structural proteins, with putative identification of three additional proteins. The SH1 genome is unique and, except for a few open reading frames, shows no detectable similarity to other published sequences, but the overall structure of the SH1 virion and its linear genome with inverted terminal repeats is reminiscent of lipid-containing dsDNA bacteriophages like PRD1.     

The application and research progress of bacteriophages in food safety

The abuse of antibiotics and the emergence of drug-resistant bacteria aggravate the problem of food safety. Finding safe and efficient antibiotic substitutes is an inevitable demand for ensuring the safety of animal-derived food. Bacteriophages are a kind of virus that can infect bacteria, fungi or actinomycetes. They have advantages of simple structure, strong specificity and nontoxic side effects for the human body. Bacteriophages can not only differentiate live cells from dead ones but also detect bacteria in a viable but nonculturable state. These characteristics make bacteriophages more and more widely used in the food industry. This paper describes the concept and characteristics of bacteriophages, and introduces the application of bacteriophages in preharvest production, food processing, storage and sales. Several methods of using bacteriophages to detect foodborne pathogens are listed. Finally, the advantages and limitations of bacteriophages in the food industry are summarized, and the application prospect of bacteriophages in the food industry is discussed.     

Sampling methodologies and dosage assessment techniques for submicrometre and ultrafine virus aerosol particles

AIMS: The aerosolization and collection of submicrometre and ultrafine virus particles were studied with the objective of developing robust and accurate methodologies to study airborne viruses. METHODS AND RESULTS: The collection efficiencies of three sampling devices used to sample airborne biological particles - the All Glass Impinger 30, the SKC BioSampler and a frit bubbler - were evaluated for submicrometre and ultrafine virus particles. Test virus aerosol particles were produced by atomizing suspensions of single-stranded RNA and double-stranded DNA bacteriophages. Size distribution results show that the fraction of viruses present in typical aqueous virus suspensions is extremely low such that the presence of viruses has little effect on the particle size distribution of atomized suspensions. It has been found that none of the tested samplers are adequate in collecting submicrometre and ultrafine virus particles, with collection efficiencies for all samplers below 10% in the 30-100 nm size range. Plaque assays and particle counting measurements showed that all tested samplers have time-varying virus particle collection efficiencies. A method to determine the size distribution function of viable virus containing particles utilizing differential mobility selection was also developed. CONCLUSIONS: A combination of differential mobility analysis and traditional plaque assay techniques can be used to fully characterize airborne viruses. SIGNIFICANCE AND IMPACT OF THE STUDY: The data and methods presented here provide a fundamental basis for future studies of submicrometre and ultrafine airborne virus particles.